Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

BACKGROUND: There is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease. It is unclear how the risk varies as exposure accumulates. METHODS: Using an administrative health-plan dataset, risk of cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorjee, Kunchok, Baxi, Sanjiv M., Reingold, Arthur L., Hubbard, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660446/
https://www.ncbi.nlm.nih.gov/pubmed/29078761
http://dx.doi.org/10.1186/s12879-017-2808-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660446/
https://www.ncbi.nlm.nih.gov/pubmed/29078761
http://dx.doi.org/10.1186/s12879-017-2808-8

Ejemplares similares